RxDoctor Payments Data

Kevin Kundis, DPM

Podiatrist · Great Falls, MTNPI 1265953822

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Sioux Surgical Inc at 30.4% of the total. Reporting peaked in 2021 at $1,309 and has fallen 76.4% since, to $309 in 2025.

$4,056in general payments, 2019–2025

Across 52 payments — averaging $77.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sioux Surgical Inc$1K
  • Active Medical, LLC$918
  • Imbed Biosciences Inc.$618
  • Smith+Nephew$249
  • Averitas Pharma Inc.$132
  • Restor3d, Inc.$126
  • plus $781 from 13 others

What the payments were for

  • Food & beverage$1,93848%
  • Education$2,11852%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sioux Surgical Inc2$1,232
Active Medical, LLC1$918
Imbed Biosciences Inc.11$618
Smith+Nephew5$249
Averitas Pharma Inc.6$132
Restor3d, Inc.1$126
Zyla Life Sciences, Inc.13$121
Deroyal Industries, Inc.1$98
Treace Medical Concepts, Inc.1$84
Medline Industries LP1$80
Stryker2$78
Alafair Biosciences, Inc.1$63
Paragon 28, Inc.1$63
GRT US Holding, Inc.1$46
Integra Lifesciences Corporation1$42
Embody, Inc.1$41
International Life Sciences1$26
Solventum Corporation1$22
In2bones USA, LLC1$18

How this compares

Too few podiatrist providers in Montanato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$162,715
Medicare patients
443
Services billed
2,174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate15$620
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$300
Meloxicam14$33

Paid to pharmacies, not to this prescriber.

Other podiatrist in Great Falls

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →